Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-031-5 | CAS number: 131-57-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from september 7, 2005 to september 21, 2005
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: LLNA test, guideline test with GLP
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- The age of the animals was 6 to 7 weeks, instead of 8 to 12 weeks and the relative humidity in the animal room was between approximately 30 - 80 %, these deviations to the study plan, however, did not affect the validity of the study,
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- Animals:
Test system:Mice, CBA/CaOlaHsd
Rationale:Recognized as the recommended test system
Source:Harlan Netherlands B.V. Postbus 6174, NL - 5960 AD Horst / The Netherlands
Number of animals for the pre-test (non-GLP): 2 females
Number of animals for the main study: 16 females
Number of animals per group: 4 females (nulliparous and non-pregnant) 3
Number of test groups: 3
Number of control (vehicle): 1
Age: 6-7 weeks(beginning of acclimatization)
Identification:Single caging. The animals will be distributed into the test groups at random and identified by cage number.
Acclimatization: Under test conditions after health examination. Only animals without any visible signs of illness will be used for the study.
Husbandry
The animals were kept conventionally. The experiment was conducted under standard laboratory conditions.
Housing: single
Cage Type: Makrolon Type I, with wire mesh top (EHRET GmbH, D-79302 Emmendingen)
Bedding: granulated soft wood bedding (Harlan Winkelmann GmbH, D-33178 Borchen)
Feed: pelleted standard diet, ad libitum(Harlan Winkelmann GmbH, D-33178 Borchen)
Water: tap water, ad libitum, (Gemeindewerke, D-64380 Rossdorf)
Environment: temperature 22±3°C relative humidity 30-80% artificial light 6.00 a.m. - 6.00 p.m. - Vehicle:
- dimethylformamide
- Concentration:
- 0 (control), 12.5, 25 and 50%
- No. of animals per dose:
- 4
- Details on study design:
- In order to study a possible allergenic potential of test article, three groups each of four female mice were treated with different concentrations of the test item by topical application at the dorsum of each ear lobe (left and right) on three consecutive days. A control group of four mice was treated with the vehicle only. Five days after the first topical application, the mice were intravenously injected into a tail vein with radio-labelled thymidine (3H-methyl thymidine). Approximately five hours after intravenous injection, the mice were sacrificed and the draining auricular lymph nodes excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3H-methyl thymidine measured in a p-scintiation counter.
- Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations were calculated in the body weight tables.
- Positive control results:
- Test item concentration
% (w/v) Group Measurement
DPM Calculation Result
DPM-BG a) number of lymph nodes DPM per lymph node b) S.I.
… BG I 11.1 --- … … …
… BG II 4.8 --- … … …
… CG 1 5836.1 5828.2 8 728.5
5 TG 2 6162.5 6154.6 8 769.3 1.06
10 TG 3 10534.7 10526.8 8 1315.8 1.81
25 TG 4 23323.7 23315.8 8 2914.5 4.00
BG = Background (1 ml 5% trichloroacetic acid) in duplicate CG = Control Group TG = Test Group
S.I. = Stimulation Index
a) = The mean value was taken from the figures BG I and BG II
b) = Since the lymph nodes of the animals of a dose group were pooled, DPM/node
was determined by dividing the measured value by the number of lymph nodes pooled
Test item concentration %
(w/v) S.I.
Group 2 10.0 (a) 1.81 (b)
Group 3 25.0 (c) 4.0 (d)
EC3 = (a-c) [(3-d)/(b-d)] + c = 18.2 % (w/v)
EC3 = Estimated concentration for a S.I. of 3.
a,b,c,d = Co-ordinates of the two pair of data lying immediately above and below the S.I. value of 3 on the LLNA dose response plot. - Parameter:
- SI
- Remarks on result:
- other: see table 1 in the field for additional information of results.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see table 1 in the field for additional information of results.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- In conclusion, test article was shown to be not a skin sensitizer in this murine local lymph node assay.
- Executive summary:
This study was performed in compliance with Good Laboratory Practice Regulations and OECD guideline 429: Skin Sensitisation. Local Lymph Node Assay (adopted 24 April 2002). Test article dissolved in DMF was assessed for its possible contact allergenic potential in the murine local lymph node assay (LLNA) in CBA/CaOlaHsd mice.
The ears of each 4 female mice were topically treated with the test item in concentrations of 0 (control), 12.5, 25 and 50% for three consecutive days. Five days after the first topical application the mice were injected intravenously with 3H-methyl thymidine. Approximately five hours thereafter, the mice were sacrificed, the draining lymph nodes excised and pooled. Single cell suspensions of lymph node cells were prepared and the incorporation of 3H-methyl thymidine was measured in a p-scintillation counter.
The animals did not show any local findings or clinical signs of systemic toxicity during the study and no mortality was observed.
The Stimulation Indices (S.I.) of 1.64, 1.33 and 1.61 were determined with the test item at concentrations of 12.5, 25 and 50% (w/v) in DMF, respectively, and thus, were clearly below the limit criterium of a S.I. of 3.
Reference
Calculation and Results of Individual Data
Test item concentration % (w/v) |
Group |
Measurement DPM |
Calculation |
Result |
||
DPM-BGa) |
number of lymph nodes |
DPM per lymph nodeb) |
S.I. |
|||
… |
BG I |
23.61 |
— |
… |
… |
… |
… |
BG II |
24.94 |
— |
… |
… |
… |
… |
CG 1 |
4310.73 |
4286.5 |
8 |
535.8 |
|
12.5 |
TG 2 |
7046.78 |
7022.5 |
8 |
877.8 |
1.64 |
25 |
TG 3 |
5740.50 |
5716.2 |
8 |
714.5 |
1.33 |
50 |
TG 4 |
6927.91 |
6903.6 |
8 |
863.0 |
1.61 |
BG = Background (1 ml 5% trichloroacetic acid) in duplicate CG = Control Group TG = Test Group
S.I. = Stimulation Index
a) = The mean value was taken from the figures BG I and BG II
b) = Since the lymph nodes of the animals of a dose group were pooled, DPM/node
was determined by dividing the measured value by the number of lymph nodes pooled.
The EC3 Value could not be calculated, since all SI's are below 3.
Viability / Mortality
No deaths occurred during the study period.
Clinical Signs
No symptoms of local toxicity at the ears of the animals and no systemic findings were observed during the study period.
Body Weights
The body weight of the animals, recorded prior to the first application and prior to treatment with 3HTdR, was within the range commonly recorded for animals of this strain and age.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The key study was performed in compliance with Good Laboratory Practice Regulations and OECD guideline 429:Skin Sensitisation. Local Lymph Node Assay. Test article dissolved in DMF was assessed for its possible contact allergenic potential in the murine local lymph node assay (LLNA) in CBA/CaOlaHsd mice.
The ears of each 4 female mice were topically treated with the test item in concentrations of0 (control), 12.5, 25 and 50%for three consecutive days. Five days after the first topical application the mice were injected intravenously with3H-methyl thymidine. Approximately five hours thereafter, the mice were sacrificed, the draining lymph nodes excised and pooled. Single cell suspensions of lymph node cells were prepared and the incorporation of3H-methyl thymidine was measured in a p-scintillation counter.
The animals did not show any local findings or clinical signs of systemic toxicity during the study and no mortality was observed.
The Stimulation Indices (S.I.) of 1.64, 1.33 and 1.61 were determined with the test item at concentrations of 12.5, 25 and 50% (w/v) in DMF, respectively, and thus, were clearly below the limit criterion of a S.I. of 3.
A supporting guinea pig maximisation test performed in 1991 also showed that the substance is not considered sensitizing.
Migrated from Short description of key information:
Test article was shown to be not a skin sensitizer in this murine local lymph node assay and this result is supported by a negative GPMT-test.
Justification for selection of skin sensitisation endpoint:
Selected because rather new study performed under GLP.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
The substance was negative when tested for skin sensitisation potential in a LLNA test according to GLP. A test result for respiratory sensitisation is not available and not required.
Human information: No human information is available.
Justification for classification or non-classification
Based on the results given in the present LLNA-skin sensitisation study, test substance does not require classification under the CLP-regulation (Regulation EC No. 1272/2008) nor under DSD (Directive 67/548/EEC).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)